BNT329
BNT329-01
Phase 2 small_molecule active
Quick answer
BNT329 for Advanced Solid Cancers is a Phase 2 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Advanced Solid Cancers
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active